Mobeen H. Rathore

TL;DR: In this paper, the distribution of lymphocyte subsets in healthy urban-dwelling infants, children, and adolescents in the United States was determined by means of 3-color flow cytometry in a cross-sectional study of 807 HIV-unexposed children from birth through 18 years of age.

TL;DR: The updated recommendations in this policy statement reflect new information regarding the seasonality of RSV circulation, palivizumab pharmacokinetics, the changing incidence of bronchiolitis hospitalizations, the effect of gestational age and other risk factors on RSV hospitalization rates, the mortality of children hospitalized with RSV infection, the effects of prophylaxis on wheezing, and palivZumab-resistant RSV isolates.

TL;DR: An open-label evaluation of intravenous acyclovir at dosages higher than the 30 mg/kg/d standard dosage approved by the US Food and Drug Administration indicated that the survival rate for patients treated with HD acy Clovir was statistically significantly higher than for patientstreated with SD acyClovir.

TL;DR: Comparisons between patients treated in the periods between 1981-1988 and 1989-1997 according to extent of disease revealed that the mean time between the onset of disease symptoms and initiation of therapy has not changed significantly from the early 1980s to the late 1990s, demonstrating that no progress has been made in decreasing the interval between onset of HSV symptoms and initiated antiviral therapy.

TL;DR: Hospital-associated infection prevalence in this pilot was similar to that reported in the 1970s by the Centers for Disease Control and Prevention's Study on the Efficacy of Nosocomial Infection Control.